Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-03

Clinical Trial Update: Examining the Effects of Cytisinicline on Neural Substrates of Cigarette Cue-reactivity [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial is evaluating cytisinicline's effects on neural substrates of cigarette cue-reactivity for smoking cessation and is currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cytisinicline

Snippet

Sponsor: University of California, Los Angeles | Conditions: Smoking Cessation, Tobacco Use Disorder | Phase 2 | Status: RECRUITING